lenalidomide has been researched along with Castleman Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Li, X; Wang, HX; Wang, L; Zhang, M; Zhong, Z | 1 |
| Jin, J; Liu, H; Lou, Y; Mao, L; Tong, H; Wei, J; Xu, G; Yang, M; Zhou, X | 1 |
| Adam, Z; Čermáková, Z; Hanke, I; Koukalová, R; Král, Z; Krejčí, M; Křen, L; Mayer, J; Michalková, E; Penka, I; Petrášová, H; Pour, L; Pourová, E; Řehák, Z; Sandecká, V; Ševčíková, S; Sokol, F; Szturz, P; Volfová, P | 1 |
| Adam, Z; Chovancová, J; Hájek, R; Klabusay, M; Koukalová, R; Krejčí, M; Mayer, J; Pour, L; Rehák, Z; Stehlíková, O; Szturz, P; Zahradová, L | 1 |
| Adami, F; Briani, C; Citton, V; Lessi, F; Manara, R; Zambello, R | 1 |
| Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Mayer, J; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L | 1 |
| Li, J; Zhou, DB | 1 |
3 review(s) available for lenalidomide and Castleman Disease
| Article | Year |
|---|---|
[Treatment of 14 cases of Castlemans disease: the experience of one centre and an overview of literature].
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Castleman Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; Remission Induction; Rituximab; Thalidomide | 2016 |
[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Topics: Aged; Castleman Disease; Erdheim-Chester Disease; Female; Histiocytosis, Langerhans-Cell; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Thalidomide | 2012 |
New advances in the diagnosis and treatment of POEMS syndrome.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2013 |
4 other study(ies) available for lenalidomide and Castleman Disease
| Article | Year |
|---|---|
Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
Topics: Antibodies, Monoclonal, Humanized; Castleman Disease; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Lenalidomide; Middle Aged; Treatment Outcome | 2019 |
Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.
Topics: Adult; Castleman Disease; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Lymph Nodes; Male; Middle Aged; Remission Induction; Salvage Therapy; Thalidomide; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
Lenalidomide: a new treatment option for Castleman disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Humans; Lenalidomide; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thalidomide; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Topics: Aged; Castleman Disease; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Osteolysis; POEMS Syndrome; Prospective Studies; Thalidomide; Vascular Endothelial Growth Factor A | 2012 |